Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Positron-Emission Tomography × 1 year × Clear all

Phase

Phase NA 7 Phase 2 6 Phase 1 5 Phase 1/2 4 Phase EARLY_PHASE1 3 Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Disease 1

Interventions

pembrolizumab 218 Carboplatin 214 Cisplatin 199 Paclitaxel 177 Gemcitabine 147 Docetaxel 124 Capecitabine 107 Cyclophosphamide 102 Pemetrexed 99 Specimen Handling 98 Dexamethasone 97 Magnetic Resonance Spectroscopy 96 Radiotherapy 91 Oxaliplatin 91 Doxorubicin 90 Fluorouracil 82 Bevacizumab 82 Nivolumab 75 Rituximab 70 Leucovorin 70 Vincristine 67 Lenalidomide 65 durvalumab 64 atezolizumab 62 Radiation 60 Etoposide 60 Irinotecan 59 Prednisone 57 130-nm albumin-bound paclitaxel 57 Letrozole 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04186845 2025-09-22

Spotlight

Blue Earth Diagnostics

Phase 3 Completed

391 enrolled 30 charts

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡